Followers | 52 |
Posts | 10874 |
Boards Moderated | 11 |
Alias Born | 06/25/2009 |
Saturday, February 22, 2020 5:32:39 PM
Item 1 – Security and Reporting Issuer
1.1 State the designation of securities to which this report relates and the name and address of the head office of the issuer of the securities.
Common shares (“Common Shares”) of International Battery Metals Ltd. pursuant to a non-brokered unit private placement of the Reporting Issuer.
International Battery Metals Ltd. (“Reporting Issuer”) 510 - 744 W. Hastings Street, Vancouver, British Columbia V6C 1A53 International Battery Metals Ltd. is a reporting issuer, in the reporting jurisdictions of British Columbia, Alberta and Ontario. The Common Shares of the Reporting Issuer are listed on the Canadian Securities Exchange and trade under the trading symbol “IBAT”.
1.2 State the name of the market in which the transaction or other occurrence that triggered the requirement to file this report took place.
This report is filed in respect of securities purchased by the Acquiror pursuant to a $0.103 USD unit non-brokered private placement of the Reporting Issuer (the “Private Placement Transaction”).
2.1 State the name and address of the acquiror.
Integra Energy Group AG (the “Acquiror”) Grafenaustrasse 5 Zug, Switzerland 6302
2.2 State the date of the transaction or other occurrence that triggered the requirement to file this report and briefly describe the transaction or other occurrence.
The Acquiror entered into a private placement subscription agreement with the reporting Issuer (the “Subscription Agreement”) for the purchase of up to 7,181,000 units at a price of $0.103 USD (approximately $0.137 CAD) per unit for total proceeds of up to $739,643 USD ( approximately $983,797 CAD). Each unit consists of one common share of the Company and one nontransferable share purchase warrant. Each warrant is exercisable to purchase an additional common share at a price of $0.103 USD (approximately $0.137 CAD) per share for a period of two years from closing of the private placement.
2
The Acquiror held 3,000,000 Common Shares and 3,000,000 Warrants on the closing Tranche 1 of the Private Placement Transaction on December 13, 2019. The Acquiror acquired a further 2,912,621 Common Shares and 2,912,621 Warrants on the closing of Tranche 2 of the Private Placement Transaction on January 22, 2020. As a result of the closing of Tranche 2 the Acquiror now owns or has control or direction over (11,825,242 common shares representing approximately 18.66 percent on a partially diluted basis) of the issued and outstanding common shares of the Reporting Issuer, assuming the exercise of the Warrants acquired pursuant to the Private Placement, triggering the filing of this report.
2.3 State the names of any joint actors.
Not Applicable
Item 3 – Interest in Securities of the Reporting Issuer
3.1 State the designation and number or principal amount of securities acquired or disposed of that triggered the requirement to file this report and the change in the acquiror’s securityholding percentage in the class of securities.
The 2,912,621 Common Shares and 2,912,621 Warrants acquired on January 22, 2020 represent the second tranche under the Subscription Agreement acquired for an aggregate consideration of $300,000 USD (approximately $399,029 CAD). The Acquiror now owns or has control or direction over (11,825,242 common shares representing approximately 18.66 percent on a partially diluted basis) of the issued and outstanding common shares of the company, assuming exercise of all warrants held by the Acquiror and triggering the requirement to file this report.
3.2 State whether the acquiror acquired or disposed ownership of, or acquired or ceased to have control over, the securities that triggered the requirement to file this report.
See Section 2.2.
3.3 If the transaction involved a securities lending arrangement, state that fact.
Not Applicable
3.4 State the designation and number or principal amount of securities and the acquiror’s securityholding percentage in the class of securities, immediately before and after the transaction or other occurrence that triggered the requirement to file this report.
https://webfiles.thecse.com/sedar_filings/00033147/2002211624411040.pdf
If THEIR IS ONE THING I AM SURE ABOUT IS I AM USUALLY WRONG
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM